The Law of Compounding Medications And Drugs: Estimates for the non-FDA approved compounded bioidentical hormone therapy combination sales of estradiol and progesterone products sold by compounding pharmacies are approximate $1.5 billion per year and the FDA-approved market approximates $625 million per year.

Thursday, July 31, 2014

Estimates for the non-FDA approved compounded bioidentical hormone therapy combination sales of estradiol and progesterone products sold by compounding pharmacies are approximate $1.5 billion per year and the FDA-approved market approximates $625 million per year.

quoted from here

No comments:

Subscribe to: Post Comments (Atom)